Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial

PURPOSE: Methylene blue (MB) has been tested as a rescue therapy for patients with refractory septic shock. However, there is a lack of evidence on MB as an adjuvant therapy, its’ optimal timing, dosing and safety profile. We aimed to assess whether early adjunctive MB can reduce time to vasopressor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibarra-Estrada, Miguel, Kattan, Eduardo, Aguilera-González, Pavel, Sandoval-Plascencia, Laura, Rico-Jauregui, Uriel, Gómez-Partida, Carlos A., Ortiz-Macías, Iris X., López-Pulgarín, José A., Chávez-Peña, Quetzalcóatl, Mijangos-Méndez, Julio C., Aguirre-Avalos, Guadalupe, Hernández, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010212/
https://www.ncbi.nlm.nih.gov/pubmed/36915146
http://dx.doi.org/10.1186/s13054-023-04397-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010212/
https://www.ncbi.nlm.nih.gov/pubmed/36915146
http://dx.doi.org/10.1186/s13054-023-04397-7

Ejemplares similares